<DOC>
	<DOCNO>NCT01455688</DOCNO>
	<brief_summary>The aim study verify effect HAART critically ill HIV infected patient . The current practice begin antiviral therapy ICU discharge , condition patient stable . The investigator hypothesis investigator improve outcome patient earlier antiviral therapy ICU . The investigator retrospective study scenario . After admission ICU , patient assign one two arm : early HAART ( within 5 day ICU admission ) conventional therapy ( initiation HAART ICU discharge ) . The following data collect : demographic variable , CD4 count , viral load , drug toxicity , opportunistic infection , hemodialysis , mechanical ventilation vasoactive drug . The patient follow determine ICU mortality , hospital mortality 6-month mortality .</brief_summary>
	<brief_title>Early Antiviral Therapy Critically Ill HIV Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<criteria>HIV infection CD4 cell count le 350 cells/mm3 within 3 month prior study entry OR CD4 cell count 350 cells/mm3 500 cells/mm3 age &gt; 55 year , coinfection HBV HCV , neoplasia , viral load &gt; 100,000 copies/ml elevate cardiovascular risk OR AIDSdefining illness Regular use HAART Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>critically ill patient</keyword>
	<keyword>HIV infection</keyword>
	<keyword>HAART</keyword>
	<keyword>mortality</keyword>
</DOC>